PT - JOURNAL ARTICLE AU - Yi, Jirong AU - Michalowska, Anna M. AU - Shanbhag, Aakash AU - Miller, Robert J.H. AU - Geers, Jolien AU - Zhang, Wenhao AU - Killekar, Aditya AU - Manral, Nipun AU - Lemley, Mark AU - Buchwald, Mikolaj AU - Kwiecinski, Jacek AU - Zhou, Jianhang AU - Kavanagh, Paul B. AU - Liang, Joanna X. AU - Builoff, Valerie AU - Ruddy, Terrence D. AU - Einstein, Andrew J. AU - Feher, Attila AU - Miller, Edward J. AU - Sinusas, Albert J. AU - Berman, Daniel S. AU - Dey, Damini AU - Slomka, Piotr J. TI - AI-based volumetric six-tissue body composition quantification from CT cardiac attenuation scans enhances mortality prediction: multicenter study AID - 10.1101/2024.07.30.24311224 DP - 2024 Jan 01 TA - medRxiv PG - 2024.07.30.24311224 4099 - http://medrxiv.org/content/early/2024/08/01/2024.07.30.24311224.short 4100 - http://medrxiv.org/content/early/2024/08/01/2024.07.30.24311224.full AB - Background Computed tomography attenuation correction (CTAC) scans are routinely obtained during cardiac perfusion imaging, but currently only utilized for attenuation correction and visual calcium estimation. We aimed to develop a novel artificial intelligence (AI)-based approach to obtain volumetric measurements of chest body composition from CTAC scans and evaluate these measures for all-cause mortality (ACM) risk stratification.Methods We applied AI-based segmentation and image-processing techniques on CTAC scans from a large international image-based registry (four sites), to define chest rib cage and multiple tissues. Volumetric measures of bone, skeletal muscle (SM), subcutaneous, intramuscular (IMAT), visceral (VAT), and epicardial (EAT) adipose tissues were quantified between automatically-identified T5 and T11 vertebrae. The independent prognostic value of volumetric attenuation, and indexed volumes were evaluated for predicting ACM, adjusting for established risk factors and 18 other body compositions measures via Cox regression models and Kaplan-Meier curves.Findings End-to-end processing time was <2 minutes/scan with no user interaction. Of 9918 patients studied, 5451(55%) were male. During median 2.5 years follow-up, 610 (6.2%) patients died. High VAT, EAT and IMAT attenuation were associated with increased ACM risk (adjusted hazard ratio (HR) [95% confidence interval] for VAT: 2.39 [1.92, 2.96], p<0.0001; EAT: 1.55 [1.26, 1.90], p<0.0001; IMAT: 1.30 [1.06, 1.60], p=0.0124). Patients with high bone attenuation were at lower risk of death as compared to subjects with lower bone attenuation (adjusted HR 0.77 [0.62, 0.95], p=0.0159). Likewise, high SM volume index was associated with a lower risk of death (adjusted HR 0.56 [0.44, 0.71], p<0.0001).Interpretations CTAC scans obtained routinely during cardiac perfusion imaging contain important volumetric body composition biomarkers which can be automatically measured and offer important additional prognostic value.Evidence before this study Fully automated volumetric body composition analysis of chest computed tomography attenuation correction (CTAC) can be obtained in patients undergoing myocardial perfusion imaging. This new information has potential to significantly improve risk stratification and patient management. However, the CTAC scans have not been utilized for body composition analysis to date. We searched PubMed and Google Scholar for existing body composition related literature on June 5, 2024, using the search term (“mortality”) AND (“risk stratification” OR “survival analysis” OR “prognostic prediction” OR “prognosis”) AND (“body composition quantification” OR “body composition analysis” OR “body composition segmentation”). We identified 34 articles either exploring body composition segmentation or evaluating clinical value of body composition quantification. However, to date, all the prognostic evaluation is performed for quantification of three or fewer types of body composition tissues. Within the prognostic studies, only one used chest CT scans but utilized only a few specified slices selected from the scans, and not a standardized volumetric analysis. None of these previous efforts utilized CTAC scans, and none included epicardial adipose tissue in comprehensive body composition analysis.Added value of this study In this international multi-center study, we demonstrate a novel artificial intelligence-based annotation-free approach for segmenting six key body composition tissues (bone, skeletal muscle, subcutaneous adipose tissue, intramuscular adipose tissue, epicardial adipose tissue, and visceral adipose tissue) from low-dose ungated CTAC scans, by exploiting existing CT segmentation models and image processing techniques. We evaluate the prognostic value of metrics derived from volumetric quantification of CTAC scans obtained during cardiac imaging, for all-cause mortality prediction in a large cohort of patients. We reveal strong and independent associations between several volumetric body composition metrics and all-cause mortality after adjusting for existing clinical factors, and available cardiac perfusion and atherosclerosis biomarkers.Implications of all the available evidence The comprehensive body composition analysis can be routinely performed, at the point of care, for all cardiac perfusion scans utilizing CTAC. Automatically-obtained volumetric body composition quantification metrics provide added value over existing risk factors, using already-obtained scans to significantly improve the risk stratification of patients and clinical decision-making.Competing Interest StatementRJM received grant support and consulting fees from Pfizer. TDR received research grant support from GE Healthcare and Advanced Accelerator Applications. AJE received speaker fees from Ionetix, consulting fees from W. L. Gore & Associates, authorship fees from Wolters Kluwer Healthcare. AJE served on a scientific advisory board for Canon Medical Systems and received grants from Attralus, Bruker, Canon Medical Systems, Eidos Therapeutics, Intellia Therapeutics, Ionis Pharmaceuticals, Neovasc, Pfizer, Roche Medical Systems, and W. L. Gore & Associates. EJM received grant support from and is a consultant for GE Healthcare. MB was supported by a research award from the Kosciuszko Foundation The American Centre of Polish Culture. DB and PS participate in software royalties for QPS software at Cedars-Sinai Medical Center. DB served as a consultant for GE Healthcare. PS received research grant support from Siemens Medical Systems, and consulting fees from Synektik S.A. Other Authors declared no competing interests.Funding StatementThis research was supported in part by Grants R01HL089765 and R35HL161195 from the National Heart, Lung, and Blood Institute/National Institutes of Health (NHLBI/NIH) (PI: Piotr Slomka).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This is a retrospective study of 11035 patients who underwent SPECT/CT cardiac perfusion imaging from four different sites (Yale University, University of Calgary, Columbia University, University of Ottawa) participating in the REgistry of Fast Myocardial Perfusion Imaging with NExt generation SPECT (REFINE SPECT).10 The study protocol complied with the Declaration of Helsinki and approval was obtained from the institutional review boards (IRB) at each participating institute. The overall study was approved by the IRB at Cedars-Sinai Medical Center, Los Angeles, California.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll implementation for the body composition approach used primarily Python-based image processing libraries including Python version 3.11.5, Scikit-image version 0.20.0 (https://scikit-image.org/), OpenCV version 4.6.0 (https://opencv.org/), and SciPy version 1.11.3 (https://scipy.org/). TotalSegmentator v2 (https://github.com/wasserth/TotalSegmentator), EAT segmentation model, and CAC segmentation model were implemented in PyTorch.8,11 All the statistical analysis was performed using RStudio 4.3.2, and the R libraries used include dplyr, tidyr, readxl, stringr, corrplot, survival, survminer, VennDiagram, gtsummary, gt, forestmodel, tidyverse, tidytidbits, adjustedCurves, and survivalAnalysis. All the experiments were completed using a desktop with Windows 10 Pro 64-bit operating system, 256GB RAM, AMD Ryzen Threadripper 3950X 24-Core Processor CPU, and NVIDIA TITAN RTX 24 GB GPU. The source code is available upon reasonable written request. Access to the code is available from the date of publication.ACMall-cause mortalityAIartificial intelligenceBMIbody mass indexCACcoronary artery calciumCTACcomputed tomography attenuation correctionEATepicardial adipose tissueIMATintramuscular adipose tissueHUHounsfield unitLVEFleft ventricular ejection fractionMPImyocardial perfusion imagingSATsubcutaneous adipose tissueSMskeletal muscleTPDtotal perfusion deficitVATvisceral adipose tissue